Ada H. C. Kung

1.2k citations

26 papers · 752 indexed · h-index 14

Co-authors: W. S. Ammons D. A. Steinberg John C. Fiddes Fang Cheng David Loury Dianne M. Fishwild Susan L. Bernhard Robert J. Bauer
Topics: Immune Response and Inflammation (8 papers)Monoclonal and Polyclonal Antibodies Research (7 papers)Toxin Mechanisms and Immunotoxins (7 papers)
Cited by: Microbiology Immunology Molecular Medicine
Journals: Journal of the American Chemical Society Journal of Biological Chemistry Blood
Partner nations: United States Argentina

In The Last Decade

Ada H. C. Kung

26 papers receiving 690 citations

Peers

Countries citing papers authored by Ada H. C. Kung

Since Specialization

Citations

This map shows the geographic impact of Ada H. C. Kung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ada H. C. Kung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ada H. C. Kung more than expected).

Fields of papers citing papers by Ada H. C. Kung

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ada H. C. Kung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ada H. C. Kung. The network helps show where Ada H. C. Kung may publish in the future.

Co-authorship network of co-authors of Ada H. C. Kung

This figure shows the co-authorship network connecting the top 25 collaborators of Ada H. C. Kung. A scholar is included among the top collaborators of Ada H. C. Kung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ada H. C. Kung. Ada H. C. Kung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Chemical Approach to the Pharmaceutical Optimization of an Anti-HIV Protein 2007 ·Journal of the American Chemical Society ·Les P. Miranda,Haiyan Shao,(unknown),Shiah-Yun Chen,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Jill Wilken,Donald E. Low,(unknown),Maia Carnevali,Alexander Lee,Di Song,Ada H. C. Kung,(unknown),Xavier Paliard,Gerd G. Kochendoerfer	11
2	Synthetic Erythropoietic Proteins: Tuning Biological Performance by Site-Specific Polymer Attachment 2005 ·Chemistry & Biology ·Shiah-Yun Chen,Sonya Cressman,Feng Mao,(unknown),Donald W. Low,Hal S. Beilan,(unknown),Maia Carnevali,(unknown),(unknown),H. Patricia Porter,(unknown),(unknown),(unknown),John W. Adamson,Carlos E. Bozzini,Ada H. C. Kung,Stephen B. H. Kent,(unknown),Gerd G. Kochendoerfer	36
3	Differential Effects of Administration of a Human Anti-CD4 Monoclonal Antibody, HM6G, in Nonhuman Primates 1999 ·Clinical Immunology ·Dianne M. Fishwild,Darryl Hudson,Usha Deshpande,Ada H. C. Kung	17
4	The Role of Liver and Kidney on the Pharmacokinetics of a Recombinant Amino Terminal Fragment of Bactericidal/Permeability-Increasing Protein in Rats 1997 ·Pharmaceutical Research ·Robert J. Bauer,(unknown),(unknown),(unknown),Ada H. C. Kung	7
5	Reproductive toxicity testing of therapeutic biotechnology agents 1996 ·Teratology ·Judith Henck,(unknown),(unknown),Joy Cavagnaro,Andrew G. Hendrickx,Narsingh D. Agnish,Ada H. C. Kung,Joyce Mordenti	23
6	A PHASE I SAFETY AND PHARMACOKINETIC STUDY OF A RECOMBINANT AMINO TERMINAL FRAGMENT OF BACTERICIDAL/ PERMEABILITY-INCREASING PROTEIN IN HEALTHY MALE VOLUNTEERS 1996 ·Shock ·Robert J. Bauer,Mark White,Nancy Wedel,Betty J Nelson,N. Friedmann,Albert Cohen,W N M Hustinx,Ada H. C. Kung	23
7	ALTERATION OF THE PHARMACOKINETICS OF SMALL PROTEINS BY IODINATION 1996 ·Biopharmaceutics & Drug Disposition ·Robert J. Bauer,Scott D. Leigh,C Birr,Susan L. Bernhard,(unknown),(unknown),(unknown),Stephen F. Carroll,Ada H. C. Kung	14
8	T Cell-targeted Immunofusion Proteins from Escherichia coli 1995 ·Journal of Biological Chemistry ·Marc Better,Susan L. Bernhard,Robert E. Williams,Scott D. Leigh,Robert J. Bauer,Ada H. C. Kung,Stephen F. Carroll,Dianne M. Fishwild	9
9	Role of endotoxin in acute inflammation induced by gram-negative bacteria: specific inhibition of lipopolysaccharide-mediated responses with an amino-terminal fragment of bactericidal/permeability-increasing protein 1995 ·Infection and Immunity ·(unknown),Ada H. C. Kung	21
10	Enhanced Stability in vitro and in vivo of Immunoconjugates Prepared with 5-Methyl-2-iminothiolane 1994 ·Bioconjugate Chemistry ·Stephen F. Carroll,Susan L. Bernhard,Dane A. Goff,Robert J. Bauer,(unknown),Ada H. C. Kung	12
11	Protective effect of a recombinant fragment of bactericidal/permeability increasing protein against carbohydrate dyshomeostasis and tumor necrosis factor-α elevation in rat endotoxemia 1994 ·Biochemical Pharmacology ·(unknown),(unknown),Ada H. C. Kung,W. S. Ammons	21
12	Protective Effects Of An N-Terminal Fragment Of Bactericidal/Permeability-Increasing Protein In Rodent Models Of Gram-Negative Sepsis: Role Of Bactericidal Properties 1994 ·The Journal of Infectious Diseases ·W. S. Ammons,(unknown),Ada H. C. Kung	30
13	Continuous Infusion Animal Model for the Immunoconjugate Xomazyme-CD5 Plus, in the Rat 1994 ·Journal of the American College of Toxicology ·Ada H. C. Kung,(unknown),(unknown),Virginia L. Mohler,Mark White	2
14	PROTECTIVE EFFECTS OF A RECOMBINANT N-TERMINAL FRAGMENT OF BACTERICIDAL/PERMEABILITY INCREASING PROTEIN ON ENDOTOXIC SHOCK IN CONSCIOUS RABBITS 1994 ·Shock ·(unknown),W. S. Ammons,W. J. Leach,Ada H. C. Kung	17
15	The bactericidal/permeability increasing protein of neutrophils is a potent antibacterial and anti-endotoxin agent in vitro and in vivo. 1994 ·PubMed ·Peter Elsbach,Jerrold Weiss,Martin E. Doerfler,Cindy C. Shu,(unknown),W. S. Ammons,Ada H. C. Kung,Károly Mészáros,J B Parent	12
16	Therapeutic proteins : pharmacokinetics and pharmacodynamics 1993 ·Ada H. C. Kung,R Baughman,James W. Larrick	12
17	Protective Effect of a Recombinant Amino-Terminal Fragment of Bactericidal/Permeability-Increasing Protein in Experimental Endotoxemia 1993 ·The Journal of Infectious Diseases ·(unknown),W. S. Ammons,Arnold H. Horwitz,Lynn S. Grinna,Georgia Theofan,Joachim L. Weickmann,Ada H. C. Kung	66
18	Efficacy of an anti-CD5-ricin a chain immunoconjugate in an improved human peripheral blood lymphocyte-reconstituted severe combined immunodeficient mouse model 1993 ·International Journal of Immunopharmacology ·(unknown),Dianne M. Fishwild,Ada H. C. Kung	3
19	Efficacy of anti-CD5 F(AB′)2 and FAB′ immunoconjugates in human peripheral blood lymphocyte-reconstituted severe combined immunodeficient mice 1993 ·International Journal of Immunopharmacology ·(unknown),Dianne M. Fishwild,Susan L. Bernhard,Marc Better,Ada H. C. Kung	4
20	Recombinant amino terminal fragment of bactericidal/permeability-increasing protein prevents hemodynamic responses to endotoxin. 1993 ·PubMed ·W. S. Ammons,Ada H. C. Kung	27

About Ada H. C. Kung

Ada H. C. Kung is a scholar working on Immunology, Biotechnology and Microbiology, having authored 26 papers that have together received 752 indexed citations. Recurring topics across this work include Immune Response and Inflammation (8 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Toxin Mechanisms and Immunotoxins (7 papers). The work is most often cited by research in Microbiology (358 citations), Immunology (337 citations) and Molecular Medicine (69 citations). Ada H. C. Kung has collaborated with scholars based in United States and Argentina. Frequent co-authors include W. S. Ammons, D. A. Steinberg, John C. Fiddes, Fang Cheng, David Loury, Dianne M. Fishwild, Susan L. Bernhard, Robert J. Bauer, Joachim L. Weickmann and Lynn S. Grinna. Their work appears in journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact